Literature DB >> 27129254

Inhibition of Proteasome Activity Induces Formation of Alternative Proteasome Complexes.

Vanessa Welk1, Olivier Coux2, Vera Kleene1, Claire Abeza2, Dietrich Trümbach3, Oliver Eickelberg1, Silke Meiners4.   

Abstract

The proteasome is an intracellular protease complex consisting of the 20S catalytic core and its associated regulators, including the 19S complex, PA28αβ, PA28γ, PA200, and PI31. Inhibition of the proteasome induces autoregulatory de novo formation of 20S and 26S proteasome complexes. Formation of alternative proteasome complexes, however, has not been investigated so far. We here show that catalytic proteasome inhibition results in fast recruitment of PA28γ and PA200 to 20S and 26S proteasomes within 2-6 h. Rapid formation of alternative proteasome complexes did not involve transcriptional activation of PA28γ and PA200 but rather recruitment of preexisting activators to 20S and 26S proteasome complexes. Recruitment of proteasomal activators depended on the extent of active site inhibition of the proteasome with inhibition of β5 active sites being sufficient for inducing recruitment. Moreover, specific inhibition of 26S proteasome activity via siRNA-mediated knockdown of the 19S subunit RPN6 induced recruitment of only PA200 to 20S proteasomes, whereas PA28γ was not mobilized. Here, formation of alternative PA200 complexes involved transcriptional activation of the activator. Alternative proteasome complexes persisted when cells had regained proteasome activity after pulse exposure to proteasome inhibitors. Knockdown of PA28γ sensitized cells to proteasome inhibitor-mediated growth arrest. Thus, formation of alternative proteasome complexes appears to be a formerly unrecognized but integral part of the cellular response to impaired proteasome function and altered proteostasis.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  PA200; PA28γ; enzyme inhibitor; proteasome; protein degradation; proteolysis; proteostasis

Mesh:

Substances:

Year:  2016        PMID: 27129254      PMCID: PMC4933230          DOI: 10.1074/jbc.M116.717652

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  70 in total

1.  Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling.

Authors:  Natura Myeku; Catherine L Clelland; Sheina Emrani; Nikolay V Kukushkin; Wai Haung Yu; Alfred L Goldberg; Karen E Duff
Journal:  Nat Med       Date:  2015-12-21       Impact factor: 53.440

Review 2.  Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors.

Authors:  Martin Rechsteiner; Christopher P Hill
Journal:  Trends Cell Biol       Date:  2005-01       Impact factor: 20.808

3.  Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands.

Authors:  T P Dick; T Ruppert; M Groettrup; P M Kloetzel; L Kuehn; U H Koszinowski; S Stevanović; H Schild; H G Rammensee
Journal:  Cell       Date:  1996-07-26       Impact factor: 41.582

4.  Proteasome allostery as a population shift between interchanging conformers.

Authors:  Amy M Ruschak; Lewis E Kay
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-12       Impact factor: 11.205

5.  Analysis of Drosophila 26 S proteasome using RNA interference.

Authors:  Cezary Wójcik; George N DeMartino
Journal:  J Biol Chem       Date:  2001-12-05       Impact factor: 5.157

6.  Proteasome activator PA200 is required for normal spermatogenesis.

Authors:  Bernard Khor; Andrea L Bredemeyer; Ching-Yu Huang; Isaiah R Turnbull; Ryan Evans; Leonard B Maggi; J Michael White; Laura M Walker; Kay Carnes; Rex A Hess; Barry P Sleckman
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

7.  Proteasome-mediated processing of Nrf1 is essential for coordinate induction of all proteasome subunits and p97.

Authors:  Zhe Sha; Alfred L Goldberg
Journal:  Curr Biol       Date:  2014-07-03       Impact factor: 10.834

8.  Role for proteasome activator PA200 and postglutamyl proteasome activity in genomic stability.

Authors:  Jennifer Blickwedehl; Manjula Agarwal; Changhyun Seong; Raj K Pandita; Thomas Melendy; Patrick Sung; Tej K Pandita; Naveen Bangia
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-09       Impact factor: 11.205

Review 9.  Recognition and processing of ubiquitin-protein conjugates by the proteasome.

Authors:  Daniel Finley
Journal:  Annu Rev Biochem       Date:  2009       Impact factor: 23.643

10.  Differential global structural changes in the core particle of yeast and mouse proteasome induced by ligand binding.

Authors:  Marcelino Arciniega; Philipp Beck; Oliver F Lange; Michael Groll; Robert Huber
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-16       Impact factor: 11.205

View more
  20 in total

1.  Physical and Functional Analysis of the Putative Rpn13 Inhibitor RA190.

Authors:  Paige Dickson; Daniel Abegg; Ekaterina Vinogradova; Junichiro Takaya; Hongchan An; Scott Simanski; Benjamin F Cravatt; Alexander Adibekian; Thomas Kodadek
Journal:  Cell Chem Biol       Date:  2020-08-27       Impact factor: 8.116

2.  The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.

Authors:  G R Tundo; D Sbardella; A M Santoro; A Coletta; F Oddone; G Grasso; D Milardi; P M Lacal; S Marini; R Purrello; G Graziani; M Coletta
Journal:  Pharmacol Ther       Date:  2020-05-19       Impact factor: 12.310

3.  Susceptibility of microtubule-associated protein 1 light chain 3β (MAP1LC3B/LC3B) knockout mice to lung injury and fibrosis.

Authors:  Vidya Sagar Kesireddy; Shashi Chillappagari; Saket Ahuja; Lars Knudsen; Ingrid Henneke; Johannes Graumann; Silke Meiners; Matthias Ochs; Clemens Ruppert; Martina Korfei; Werner Seeger; Poornima Mahavadi
Journal:  FASEB J       Date:  2019-08-20       Impact factor: 5.191

4.  Approaches to Evaluate the Impact of a Small-Molecule Binder to a Noncatalytic Site of the Proteasome.

Authors:  Wenzhi Tian; Marianne E Maresh; Darci J Trader
Journal:  Chembiochem       Date:  2021-03-26       Impact factor: 3.461

5.  The 11S Proteasomal Activator REGγ Impacts Polyglutamine-Expanded Androgen Receptor Aggregation and Motor Neuron Viability through Distinct Mechanisms.

Authors:  Jill M Yersak; Heather L Montie; Erica S Chevalier-Larsen; Yuhong Liu; Lan Huang; Martin Rechsteiner; Diane E Merry
Journal:  Front Mol Neurosci       Date:  2017-05-24       Impact factor: 5.639

Review 6.  Proteasome Inhibitors: Harnessing Proteostasis to Combat Disease.

Authors:  David J Sherman; Jing Li
Journal:  Molecules       Date:  2020-02-05       Impact factor: 4.411

7.  Proteasome activator PA200 regulates myofibroblast differentiation.

Authors:  Vanessa Welk; Thomas Meul; Christina Lukas; Ilona E Kammerl; Shrikant R Mulay; Andrea C Schamberger; Nora Semren; Isis E Fernandez; Hans-Joachim Anders; Andreas Günther; Jürgen Behr; Oliver Eickelberg; Martina Korfei; Silke Meiners
Journal:  Sci Rep       Date:  2019-10-23       Impact factor: 4.379

8.  Tumors escape immunosurveillance by overexpressing the proteasome activator PSME3.

Authors:  Mathilde Boulpicante; Romain Darrigrand; Alison Pierson; Valérie Salgues; Marine Rouillon; Benoit Gaudineau; Mehdi Khaled; Angela Cattaneo; Angela Bachi; Paolo Cascio; Sébastien Apcher
Journal:  Oncoimmunology       Date:  2020-05-21       Impact factor: 8.110

9.  PIP30/FAM192A is a novel regulator of the nuclear proteasome activator PA28γ.

Authors:  Beata Jonik-Nowak; Thomas Menneteau; Didier Fesquet; Véronique Baldin; Catherine Bonne-Andrea; Francisca Méchali; Bertrand Fabre; Prisca Boisguerin; Sylvain de Rossi; Corinne Henriquet; Martine Pugnière; Manuelle Ducoux-Petit; Odile Burlet-Schiltz; Angus I Lamond; Philippe Fort; Séverine Boulon; Marie-Pierre Bousquet; Olivier Coux
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-22       Impact factor: 11.205

10.  Inhibition of the proteasome and proteaphagy enhances apoptosis in FLT3-ITD-driven acute myeloid leukemia.

Authors:  Rosa G Lopez-Reyes; Grégoire Quinet; Maria Gonzalez-Santamarta; Clément Larrue; Jean-Emmanuel Sarry; Manuel S Rodriguez
Journal:  FEBS Open Bio       Date:  2020-11-24       Impact factor: 2.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.